Transcript Highlights:

• In 2024, and now published in a peer-reviewed publication, the FDA published a dose-finding study that
• importance of actual safety for consumers by determining that there is a human study funded by the FDA
• That is not the purpose of the FDA adverse event system.
• It is to let the FDA determine what is unsafe.
• What I said was HHS, FDA, NIDA, and the Arizona AG all agree that 7-OH should be regulated and not allowed

Bills: HB2028, HB2047, HB2136, HB2244, HB2364, HB2406, HB2415, HB2557, HB2573, HB2589, HB2720, HB2749, HB2825, HB2861, HB2862, HB2870, HB2970, HB4070, HB4117, HCR2004, HCR2051

Keywords: community restitution, homelessness, indigence, court assessments, monetary obligations, forcible entry, detainer, writ of restitution, criminal trespass, judgment enforcement, civil terrorism, disorderly conduct, vandalism, political activism, public order, subversion, government security, evictions, judgment satisfaction, tenant rights

Summary: The committee first heard HB 2825, which would replace criminal enforcement tools for nonpayment of fines, fees, restitution, and related obligations with a civil collection process. Supporters, including the sponsor, argued it would streamline restitution collection and reduce costly incarceration, while opponents from victims’ rights groups, judges, and prosecutors said it would weaken victims’ constitutional rights and remove effective enforcement leverage. The chair adopted an amendment requiring a summons and clarifying that victims’ constitutional remedies are preserved, and the committee passed the bill 5-2. The committee then considered HB 4070, which would bar corporations from incorporating if an officer, director, or trustee had been convicted of sex or human trafficking, and would extend civil liability to those who facilitate trafficking. Supporters framed it as a “corporate death penalty” aimed at preventing trafficking through corporate governance, while the ACLU warned the facilitation language was vague and could sweep too broadly. After adopting the chair’s amendment defining “facilitate,” the committee passed the bill 5-2. The committee also unanimously recommended confirmation of Neil McDowell to the Arizona Board of Executive Clemency after hearing his background in corrections and his plans to review cases thoroughly and efficiently. Next, HB 2720 was heard, which would raise penalties for paying or agreeing to pay for sexual conduct, add a $200 assessment for the anti-human trafficking fund, and allow certain sex-trafficking victims convicted of prostitution to seal vacated records. Supporters, including law enforcement, prosecutors, and survivor advocates, said it would deter demand and help victims; opponents argued it could still sweep in trafficking victims and lacked sufficient safeguards. The committee passed the bill 4-3. The committee also heard HB 2028, a strike-everything amendment allowing community restitution in lieu of a $20 assessment for indigent homeless defendants, and HB 2047, which would increase trespass penalties for remaining in or returning to property after an eviction writ; both were discussed but no final vote is reflected in the transcript excerpt. Additional bills were introduced and heard later in the meeting, including HB 2136, which would create new offenses for “civil terrorism” and “subversion” and increase penalties for certain highway obstruction; the ACLU opposed it as viewpoint discrimination. HB 2406 would make images and recordings of abused children and deceased minors confidential and restrict dissemination and monetization; the sponsor said it was intended to prevent re-victimization and misuse of public records, while defense-side speakers asked for clearer access for defense teams. HB 2415 would tighten regulation of kratom products and specifically target concentrated 7-OH products; testimony sharply split between supporters who described public-health risks and opponents who said prohibition would harm consumers who use it for pain or recovery. The transcript ends before any final action on those later bills is shown.

Transcript Highlights:

• Both are critical funding for consumer protections at the state level as the FDA suspends quality control
• Both are critical funding for consumer protections at the state level as the FDA suspends quality control
• Both are critical funding for consumer protections at the state level as the FDA suspends quality control
• Both are critical funding for consumer protections at the state level as the FDA suspends quality control
• Both are critical funding for consumer protections at the state level as the FDA suspends quality control

Keywords: 1183, house

Transcript Highlights:

• So they are FDA approved for glioblastoma.
• They actually just made breaking news about a month or two ago, where they have now FDA approval for
• their tumor-treating fields for pancreatic cancer, and it was so significant that the FDA released its
• for where they have now FDA approval for their<01:09:52.319> tumor<01:09:52.640> treating<
• that the FDA released its own<01:09:58.640> press<01:09:58.960> release<01:09:59.360><

Keywords: 1189, house, all

Transcript Highlights:

• So they are, it does for any FDA approved indication for the drug.
• So they are, it does for any FDA approved indication for the drug.
• Um, they are all technically, um, FDA, when they are FDA indicated for weight loss, then Medicaid agencies
• Um, they are all technically, um, FDA, when they are FDA indicated for weight loss, then Medicaid agencies
• Um, they are all technically, um, FDA, when they are FDA indicated for weight loss, then Medicaid agencies

Bills: HB2488, HB2456

Keywords: disability, communication access, deaf, hard-of-hearing, deaf-blind, healthcare, sign language interpreters, auxiliary aids, weight loss, GLP-1 drugs, obesity, Medicaid, healthcare costs, 910, house, all

Summary: The committee heard testimony on HP 1972, which would create a nonrefundable family caregiver tax credit, and on a related tax measure to increase the existing dependent care tax credit. Supporters of HP 1972, including AARP, the Executive Office on Aging, the Hawaii Public Health Institute, Hawaii Children’s Action Network, and others, said unpaid caregivers are essential to keeping kūpuna and other loved ones at home and described significant out-of-pocket costs. The Department of Taxation and the Tax Foundation raised technical concerns, including the need to avoid overlap with existing credits and to prevent double-dipping. The department said taxpayers can claim credits to the extent allowed, but recommended explicit language barring the same costs from being claimed under more than one credit. No vote was taken in the excerpt, and the chair moved the bill along after questions. The committee then heard HP 1975, which would repeal the sunset on the state rent supplement program for kūpuna. AARP, Catholic Charities Hawaii, the Executive Office on Aging, and others supported making the program permanent, saying it helps low-income older adults avoid eviction and homelessness and allows them to remain in affordable housing. Catholic Charities described clients who were paying unsustainable shares of income for rent before receiving the supplement. Members also shared a constituent example of an elderly retiree who needed the subsidy to stay housed. Written support was noted from additional organizations and individuals. Next, the committee took up HB 1706, which would expand Medicaid prospective payment reimbursement to include mental health services furnished in federally qualified health centers and rural health clinics by mental health professionals under supervision. The Office of Hawaiian Affairs supported the bill, and DHS said it appreciated the intent to address workforce shortages and expand training, but cautioned that unlicensed professionals cannot currently bill Medicaid and that a state plan amendment would be needed, with limited precedent for approval. Members asked about the likelihood and timing of federal approval and whether the bill could help rural areas; DHS said approval is uncertain and the process can take time, though it saw possible alignment with the state’s rural health transformation efforts. The committee also discussed HB 546, a three-year health coverage continuity pilot program for people losing Medicaid coverage. DHS, the Attorney General’s office, DCCA, Catholic Charities, the University of Hawaii, and others testified, with DHS warning that federal changes could increase uninsured rates and that the state may need to act quickly. Catholic Charities and others emphasized the risk to Medicaid recipients, including homeless and near-elderly residents, while DHS explained the state’s existing premium assistance program for certain immigrants and compared it to the proposed pilot. The excerpt ends during discussion of that comparison, with no vote shown.

Transcript Highlights:

• Specifically, Mifeprestone, a common and safe medication abortion drug first approved by the FDA in 2000
• It's the least invasive option for abortion care based on decades of FDA research.
• It's because the FDA, under political pressure, has stripped away nearly all original safety protocols
• Originally the FDA required that miflopristone only be dispensed in person by a certified physician after

Keywords: 988, house, all

Bills: SB2960, SB2347, SB2272, SB3137, SB3132, SB2271, SB2804, SB2175, SB2487

Keywords: homeowners insurance, disaster recovery, replacement cost value, state of emergency, policyholder rights, insurance extensions, tenant rights, landlord obligations, housing crisis, eviction prevention, multilingual access, SB2272, Act 105, home health licensing, home health agency, home health services, Department of Health, DOH, CMS, Centers for Medicare and Medicaid Services

Summary: The committee heard several resolutions and one bill focused on energy reliability, utility infrastructure, insurance, tenant rights, and home health licensing. On the energy side, members heard HCR 203/HR 193 on a status update for the Hawaii Electric Reliability Administrator, HCR 204/HR 194 on a comprehensive PUC analysis of cost reduction and risk, and HCR 202/HR 192 creating a legislative task force on future energy pathways. Testimony on the energy measures was generally supportive from the PUC, DCCA’s Division of Consumer Advocacy, the Hawaii State Energy Office, and the Office of Hawaiian Affairs, with OHA urging that equity, native Hawaiian impacts, and public trust resources be considered alongside cost savings. The committee also heard HCR 125/HR 117 on coordinating with utilities to address aging utility poles and lines along Farrington Highway and other high-risk corridors; Hawaiian Electric supported the measure, Hawaiian Telcom and Charter Spectrum said much of the work is already underway and questioned whether the resolution was necessary, and committee questioning focused on existing double-pole tracking and the role of DOT and the PUC. The committee then took up HCR 137/HR 129 on timely reimbursement of health care claims under the clean claims statute. The DCCA Insurance Division and the Hawaii Insurers Council opposed the measure as drafted, saying it could be read to require payment beyond policy limits and could raise premiums or reduce market participation. United Policyholders supported the measure, arguing it would simply give policyholders more time to collect benefits they already purchased, and clarified that it was not intended to increase coverage beyond policy limits. The committee later amended the resolution to direct the DCCA Insurance Division to prioritize investigation and enforcement of clean claims complaints. In the decision meeting, the committee recommended and adopted passage of HCR 203/HR 193 as is, HCR 204/HR 194 with an amendment removing the eighth whereas clause, HCR 202/HR 192 with an amendment adding a committee representative to the task force, HCR 125/HR 117 as is, and HCR 137/HR 129 with amendments. The committee also heard SB 2960 SC1 on property insurance, which would extend the time policyholders have after a declared disaster to document replacement-cost claims. The Insurance Division and Hawaii Insurers Council opposed it, warning it could force coverage beyond policy limits and increase premiums, while United Policyholders supported it and said it would help disaster survivors recover benefits they already paid for; members questioned whether similar laws in other states had caused premium spikes and clarified that the bill was not intended to exceed policy limits. The committee also heard SB 2347 SD1 on multilingual tenant-rights notices, with OHA, Hawaii Appleseed, and others supporting the bill but urging restoration of language requiring landlords to directly provide the notice at lease signing. Finally, SB 2272 SD1 HD1 on home health licensing drew support from the Department of Health, SHPDA, and the Health Care Association of Hawaii, with the association requesting an effective date amendment; testimony explained that the bill would allow state licensing compliance to be demonstrated through CMS-approved accreditation or certification surveys, potentially reducing duplication and freeing state resources.

Transcript Highlights:

• So, when the FDA was asked by Congress to define very small food businesses, they said they set it at
• So we're very rapidly heading for the FDA defining very small food businesses as $1.34 million.
• In the United States, the CDC, NIH, and FDA all define a rare disease as one that affects fewer than

Bills: HB3772, HB1656, HB4504, HB1896, HB4420, HB4421, HB4076, HB3708, HB2806, HB3540, HB1586, HB5459, HB4553, HB4535, HB3811, HB3749, HB4255, HB4051, HB5098, HB3554, HB4539, HB5274

Keywords: e-cigarettes, health and safety, regulations, directory, penalties, regulation, certification, compliance, manufacturers, FDA, nicotine, mental health, emergency detention, paramedic authority, mental illness, healthcare facility, public health, covenants not to compete, health care practitioners, physicians

Bills: HB3772, HB1656, HB4504, HB1896, HB4420, HB4421, HB4076, HB3708, HB2806, HB3540, HB1586, HB5459, HB4553, HB4535, HB3811, HB3749, HB4255, HB4051, HB5098, HB3554, HB4539, HB5274

Keywords: e-cigarettes, health and safety, regulations, directory, penalties, regulation, certification, compliance, manufacturers, FDA, nicotine, mental health, emergency detention, paramedic authority, mental illness, healthcare facility, public health, covenants not to compete, health care practitioners, physicians

Transcript Highlights:

• So when it comes to drugs, we are following the FDA...
• Under this definition, there are quite a few instances where we would no longer be following those FDA

Bills: SB128, SB640, SB672, SB904, SB1141, SB1263, SB1525, SB1528, SB2041, SB2306, SB2308, SB2357, SB2446, SB2695, SB2857, SB2891, SB2583

Keywords: hospital reporting, child abuse, neglect, administrative penalty, medical ethics, child protection, SB 640, Texas Family Code, Department of Family and Protective Services, DFPS, child welfare, foster care, managing conservatorship, suicide attempt, youth suicide, mental health, child protective services, state custody, annual report, reporting requirements

Bills: HB44, HB2200, HB1612, HB2747, HB2038, HB3717, HB1431, HB3800, HB3801, HB3560, HB3246, HB44

Keywords: HB 44, Life of the Mother Act, abortion exceptions, medical emergency, reasonable medical judgment, pregnancy complications, maternal health, life-threatening condition, ectopic pregnancy, miscarriage, spontaneous abortion, fetal survival, Texas abortion law, abortion ban, physician liability, health care provider, disciplinary action, aiding and abetting, emergency abortion, obstetric care

Transcript Highlights:

• So, currently the FDA has only...
• Investigations, detailed how the PSI reports detailed how data was suppressed by federal agencies, i.e., CDC and FDA
• ,” by federal agencies, i.e., CDC and FDA, vaccine manufacturers, and news media.

Keywords: 928, house, all

Summary: The Special Committee on COVID Response Efficacy met to review its mission, approve prior minutes at a future meeting, and discuss materials related to COVID-19 vaccination guidance. Members examined a pediatric vaccination handout from a private pediatric practice and compared it with New Hampshire DHHS and AAP/AAFP immunization guidance, focusing on how COVID-19 vaccine recommendations are presented for children and adults. Committee members also discussed the scope and accuracy of the committee’s endnotes and supporting documents. The main business was a draft letter urging the governor to direct state agencies to stop recommending COVID-19 mRNA vaccines. Members revised the letter paragraph by paragraph, including changing wording about age ranges for children, clarifying references to the American Academy of Pediatrics, and adding discussion of vaccine safety concerns, alleged suppression of safety data, and federal investigations. They also debated whether to reference specific reporting systems such as VAERS and V-safe, and whether to include examples from other states, including Tennessee, Arizona, Minnesota, and Florida, as evidence of broader concern about mRNA vaccines. After the edits were completed, Representative Villio moved to accept the letter as amended, Representative Leroy seconded, and the committee approved it by voice vote 4-0. The chair said the revised letter would be finalized and distributed later in the week. The meeting then adjourned at approximately 11:57 a.m.

Transcript Highlights:

• nasal epinephrine, to be inclusive of future FDA-approved pre-dosed epinephrine.
• epinephrine in schools in August of 2024 epinephrine in schools in August of 2024 the<00:08:15.000> FDA
• 16.039> new<00:08:16.319> form<00:08:16.680> of<00:08:16.840> predosed the FDA
• approved a new form of predosed the FDA approved a new form of predosed epinephrine<00:08:18.080>
• nasal epinephrine, to be inclusive of future FDA-approved pre-dosed epinephrine.

Keywords: 1183, house

Transcript Highlights:

• The FDA has no medical recommendation for it.
• The FDA does not recognize it. So those were just to answer your questions.
• <02:06:37.520> Um The FDA does not recognize it. Um The FDA does not recognize it.
• <02:30:59.439> 29th,<02:31:00.000> 2025 The FDA in a July 29th, 2025 The FDA in a July
• So, it hasn't gone through FDA testing. It doesn't have industry sponsors.

Keywords: 1189, house, all

Transcript Highlights:

• Livanova, the manufacturer of the vagal nerve simulator, as approved by the FDA.
• about this type of treatment being used for off-label purposes now a lot more, and, of course, is not FDA-approved
• Would this be limited to FDA-approved use? Madam Chair, Representative Jones, that is the goal.
• And until those are FDA approved, they're considered an off-label use, as you know.
• And until those are FDA approved, they're considered an off-label use, as you know.

Keywords: 996, all

Transcript Highlights:

• Right now, there are 40 FDA-authorized reusable vapes available for purchase that are refillable and
• Right now, there are 40 FDA-authorized reusable vapes available for purchase that are refillable and
• The other FDA-authorized vapes previously mentioned...
• The other FDA-authorized vapes previously mentioned are flavored, so they're not allowed in California
• There are 40 FDA-approved devices that could be used with nicotine, so it's one product.

Keywords: 987, senate, all

Transcript Highlights:

• The FDA requires an in-person VCPR, as well as the USDA for various reasons.
• That's why the FDA makes it absolutely crucial that you have a Veterinary-Client-Patient Relationship
• Any vaccine has to be evaluated as a new animal drug. by the FDA, but it is also evaluated for livestock
• Three companies have received FDA approval. to sell their products in the U.S. and, as Karl Ray talked
• And in 2019, President Trump's USDA and FDA developed a formal agreement... to ensure cell-cultivated

Bills: SB34, SB119, SB261, SB532, SB1035, SB1245, SB1247, SB1267, SB1442, SB1930, SB1948, SB2078, SB2112, SB2143, SB2155

Keywords: wildfire, wildfire mitigation, wildfire prevention, volunteer fire department, Texas A&M Forest Service, West Texas A&M University, prescribed burning, fuel loading, fuel reduction, firefighting equipment database, emergency communications, disaster preparedness, rural fire protection, asset hardening, natural resource management, emergency management, large wildfire risk, fire grant funding, fire suppression, Texas Legislature

Transcript Highlights:

• treatments would be investigational treatments that are currently being used in the United States but not FDA
• required to And it's just that it's a treatment that is being shown to work but hasn't gotten total FDA

Bills: SB206, SB904, SB933, SB1436, SB1500, SB1553, SB1557, SB1567, SB1644, SB1645, SB1651, SB1794, SB1833, SB1849, SB1984

Keywords: SB206, emergency medical services, EMS, ambulance, 911 response, emergency response, essential services, federal funding, grant funding, public health, health care facility, municipality, county, ambulance service district, tribal entity, public entity, contract ambulance service, Oklahoma, 63 O.S. 2021 Section 1-2502, emergency clause

Transcript Highlights:

• Now, there are several FDA-approved medications for opioid use disorder, which function...
• Now, there are several FDA-approved medications for opioid use disorder, which function by alleviating
• So that's FDA, the IRS, the U.S. Attorney's Office.
• But according to a 2025 FDA report, 7-OH produces respiratory depression at a rate three times that of
• “The sale of a new drug without FDA approval and the rigorous safety testing required for such approval

Summary: The meeting focused on Missouri’s substance use prevention and treatment system, with repeated emphasis on recovery support services, peer support, recovery housing, transportation, and harm reduction. Dan Haniken of Into Action described his own recovery from addiction and incarceration and argued that treatment alone is not enough; he urged greater investment in recovery housing, peer support, employment, and community-based supports that help people stay sober and avoid relapse. Members asked about funding sources, program capacity, referrals, treatment court, transportation, and how Into Action supports people on medication-assisted treatment (MAT). Haniken said the organization is funded through a mix of federal, state, county, city, foundation, and private donations, and that housing and transportation remain major barriers, especially because support is often funded for too short a period compared with the longer time people need to stabilize. Matt Cushman of the Raytown Fire Protection District gave a strong endorsement of harm reduction, including naloxone distribution, syringe service programs, and broader decriminalization of harm reduction tools. He argued that stigma is a major barrier to care and that Missouri should expand access to clean needles, test strips, and other services, while also improving access to MAT in jails and communities. Committee members questioned the evidence base, the role of faith-based providers, and whether safe consumption sites should be pursued; Cushman said syringe exchange decriminalization should be the immediate priority, while safe consumption sites are a longer-term issue. He also described community paramedicine and mobile integrated health as valuable but funding-dependent, and said naloxone distribution is improving but still uneven, especially in rural and minority communities. Representatives from Central Ozarks Medical Center and Four Rivers Community Health Center highlighted the importance of peer support specialists, community health workers, care coordinators, and wraparound services in rural health centers. COMC’s Morgan McClure and Monet Lehman described a jail reentry program in Pulaski County, with Lehman sharing her trauma and recovery story and explaining how she helps incarcerated people prepare for release with housing, employment, benefits, transportation, and treatment connections. Four Rivers’ Devon Polarys and Cassandra Trout said their CEO would change Missouri policy to allow FQHCs to receive reimbursement for peer support and community health worker services similar to CCBHCs, arguing that these roles are essential for addressing barriers like transportation, housing, food insecurity, and insurance. Members discussed confusion over reimbursement rules, the differences between FQHCs and CCBHCs, and the need for better funding and clearer policy for peer and community health worker services. No votes were taken; the discussion ended with a suggestion to bring in a subject matter expert on community health workers for a future session.

Transcript Highlights:

• Despite FDA approval for over-the-counter or OTC use Medi-Cal still requires a prescription for opal
• They're FDA-approved, 98% effective with adherence, safe even in patients with hypertension and smoking
• I was thrilled when the FDA approved the first over-the-counter contraceptive pill, Opil.

Keywords: 988, house, all

Transcript Highlights:

• In Alabama, you have to have applied for a pre-market tobacco application with the FDA to sell vaping
• foremost, this bill is premature, given the fact that we are still awaiting a Supreme Court decision in FDA
• This case challenges whether the FDA overstepped its authority in regulating electronic nicotine delivery

Bills: SB210, SB225, HB280, HB287, HB94, HB88, SB157, HB7, HB8, HB42

Keywords: hospital liens, medical billing, government healthcare, insurance claims, patient rights, blood tests, DUI, law enforcement, traffic offenses, chemical analysis, public nuisance, event liability, local government, community health, legal action, transparency, reporting, public safety, regulation, accountability